230 related articles for article (PubMed ID: 14729742)
1. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.
Pag U; Oedenkoven M; Papo N; Oren Z; Shai Y; Sahl HG
J Antimicrob Chemother; 2004 Feb; 53(2):230-9. PubMed ID: 14729742
[TBL] [Abstract][Full Text] [Related]
2. Synthetic diastereomeric-antimicrobial peptide: antibacterial activity against multiple drug resistant clinical isolates.
Park SC; Kim JY; Lee JK; Yoo S; Kim H; Seo CH; Nah JW; Hahm KS; Park Y
Biopolymers; 2011; 96(2):130-6. PubMed ID: 20564032
[TBL] [Abstract][Full Text] [Related]
3. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action.
Avrahami D; Shai Y
Biochemistry; 2003 Dec; 42(50):14946-56. PubMed ID: 14674771
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
Lee DL; Hodges RS
Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
[TBL] [Abstract][Full Text] [Related]
5. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
[TBL] [Abstract][Full Text] [Related]
6. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities.
Yang ST; Shin SY; Hahm KS; Kim JI
Int J Antimicrob Agents; 2006 Apr; 27(4):325-30. PubMed ID: 16563706
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
9. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria.
Hale JD; Hancock RE
Expert Rev Anti Infect Ther; 2007 Dec; 5(6):951-9. PubMed ID: 18039080
[TBL] [Abstract][Full Text] [Related]
10. Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'.
Pag U; Oedenkoven M; Sass V; Shai Y; Shamova O; Antcheva N; Tossi A; Sahl HG
J Antimicrob Chemother; 2008 Feb; 61(2):341-52. PubMed ID: 18174202
[TBL] [Abstract][Full Text] [Related]
11. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity.
Sader HS; Fedler KA; Rennie RP; Stevens S; Jones RN
Antimicrob Agents Chemother; 2004 Aug; 48(8):3112-8. PubMed ID: 15273128
[TBL] [Abstract][Full Text] [Related]
12. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.
Tian ZG; Dong TT; Teng D; Yang YL; Wang JH
Appl Microbiol Biotechnol; 2009 Apr; 82(6):1097-103. PubMed ID: 19148638
[TBL] [Abstract][Full Text] [Related]
13. Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity.
Mangoni ML; Papo N; Mignogna G; Andreu D; Shai Y; Barra D; Simmaco M
Biochemistry; 2003 Dec; 42(47):14023-35. PubMed ID: 14636071
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
J Antimicrob Chemother; 2008 May; 61(5):1092-8. PubMed ID: 18310135
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.
Critchley IA; Green LS; Young CL; Bullard JM; Evans RJ; Price M; Jarvis TC; Guiles JW; Janjic N; Ochsner UA
J Antimicrob Chemother; 2009 May; 63(5):954-63. PubMed ID: 19258353
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of tigecycline against clinical isolates from Shanghai, China.
Zhang YY; Zhou L; Zhu DM; Wu PC; Hu FP; Wu WH; Wang F
Diagn Microbiol Infect Dis; 2004 Dec; 50(4):267-81. PubMed ID: 15582300
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.
Chou HT; Kuo TY; Chiang JC; Pei MJ; Yang WT; Yu HC; Lin SB; Chen WJ
Int J Antimicrob Agents; 2008 Aug; 32(2):130-8. PubMed ID: 18586467
[TBL] [Abstract][Full Text] [Related]
18. Ceragenins: cholic acid-based mimics of antimicrobial peptides.
Lai XZ; Feng Y; Pollard J; Chin JN; Rybak MJ; Bucki R; Epand RF; Epand RM; Savage PB
Acc Chem Res; 2008 Oct; 41(10):1233-40. PubMed ID: 18616297
[TBL] [Abstract][Full Text] [Related]
19. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
[TBL] [Abstract][Full Text] [Related]
20. Novel antimicrobial peptides that exhibit activity against select agents and other drug resistant bacteria.
Venugopal D; Klapper D; Srouji AH; Bhonsle JB; Borschel R; Mueller A; Russell AL; Williams BC; Hicks RP
Bioorg Med Chem; 2010 Jul; 18(14):5137-47. PubMed ID: 20558071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
